Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755856PMC

Publication Analysis

Top Keywords

suppository diclofenac
4
diclofenac intravenous
4
intravenous meperidine
4
meperidine postoperative
4
postoperative management
4
suppository
1
intravenous
1
meperidine
1
postoperative
1
management
1

Similar Publications

Aims: With the growing evidence of cardiovascular risks associated with diclofenac use, regulatory measures governing its application and sales have intensified since 2008. We evaluated the association between central regulatory actions and trends in diclofenac use in Denmark from 1999 to 2023, according to different dosage forms and routes of administration.

Methods And Results: Data on diclofenac sales in Denmark from 1999 to 2023 were retrieved from the publicly available web database MEDSTAT, based on the Danish Register of Medicinal Products Statistics.

View Article and Find Full Text PDF

Introduction: Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used for pain disorders and exert pharmacological effects by inhibiting cyclooxygenase (COX). Although previous studies have evaluated the COX inhibitory activity and selectivity of NSAIDs, none has compared COX inhibitory concentrations with the plasma concentrations of clinical doses or investigated the efficacy and adverse effects of different dosage forms. Therefore, in this study we evaluated the COX inhibitory activities and inhibition rates of clinical doses of the various NSAID formulations, especially diclofenac sodium.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess the effectiveness and safety of rectal diclofenac for managing postoperative pain in women undergoing diagnostic hystero-laparoscopy and dye test.
  • In a double-blind, placebo-controlled trial with 108 participants, pain levels were measured at various time points, showing diclofenac provided slightly lower pain scores but not significantly better than the placebo.
  • Overall, while rectal diclofenac was deemed safe, it did not substantially enhance pain relief or patient satisfaction when compared to placebo treatments following surgery.
View Article and Find Full Text PDF

Endoscopic ultrasound (EUS) with fine needle aspiration or fine needle biopsy is the gold standard for sampling tissue to diagnose pancreatic cancer and autoimmune pancreatitis or to analyze cyst fluid. The most common reported adverse event of fine needle aspiration and/or fine needle biopsy is acute pancreatitis, which is likely induced by the same pathophysiological mechanisms as after endoscopic retrograde cholangiopancreatography (ERCP). According to the current European Society of Gastrointestinal Endoscopy guideline, nonsteroidal anti-inflammatory drugs are administered prior to ERCP as a scientifically proven treatment to reduce post-ERCP pancreatitis incidence rate.

View Article and Find Full Text PDF

We report 3 cases of patients with gastrointestinal cancer who were treated with a regimen including oxaliplatin(OX). The patients were presented with fever over 38.0℃, probably due to OX.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!